Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis

REFERENCES

• Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481–94.
   PubMed Web of Science ®Google Scholar
• Chang CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM. Increased coronary-artery ath-erosclerosis in rheumatoid arthritis: relationship to disease dura-tion and cardiovascular risk factors. Arthritis Rheum. 2005;52: 3045–53.
   Google Scholar
• Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Schwartz JE, Levine DM, Salmon JE. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249–56.
   Google Scholar
• del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737–45.
   Google Scholar
• Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88:119–24.
   Google Scholar
• Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, com-munity-wide perspective. J Am Coll Cardiol. 2001;37:1571–80.
   PubMed Web of Science ®Google Scholar
• Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, Tomioka N, Okayama A, Nakamura Y, Abbott RD, Ueshima H. Trend of increase in the incidence of acute myocardial infarction in a Japanese Population. Takashima AMI Registry, 1990–2001. Am J Epidemiol. 2008;167: 1358–64.
   Google Scholar
• Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Ishimura E, Inui K, Yutani Y, Mild T, Shoji T, Nishizawa Y. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1489–97.
   PubMed Web of Science ®Google Scholar
• Wada Y, Kuroda T, Murasawa A, Tanabe N, nakano M, Gejyo F. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2005;23:482–6.
   PubMed Web of Science ®Google Scholar
• Simonet WS, lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–19.
   PubMed Web of Science ®Google Scholar
• Golledge J, Mccann M, Mangan S, Lam A, Karan M. Osteo-protegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke. 2004;35: 1636–41.
   Google Scholar
• Montecucco F, Steffens S, Mach F. The immune response is involved in atherosclerotic plaque calcification: could the RANKURANK/OPG system be a marker of plaque instability? Clin Dev Immunol. 2007;2007: 75805.
   Google Scholar
• Venuraju SM, Yerranasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol. 2010;55:2049–61.
   PubMed Web of Science ®Google Scholar
• Jono S, Ikari Y, Shioi A, Mori K, Mild T, Hara K, Nishizawa Y. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation. 2002;106: 1192–4.
   Google Scholar
• Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation. 2004;109:2175–80.
   PubMed Web of Science ®Google Scholar
• Semb AG, Ueland T, Aukrust P, Wareham NJ, Luben R, Gullestad L, Kastelein JJ, Khaw KT, Boekholdt SM. Osteopro-tegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993–2003. Arterioscler Thromb Vasc Biol. 2009;29: 975–80.
   Google Scholar
• Haynes DR, Barg E, Crotti TN, Holding C, Weedon H, Atkins GJ, et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology. 2003;42:123–34.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:315–24.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   Google Scholar
• Sharp JT, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, Genant HK, Gofton JP, Goodman N, Larsen A, Lipsky MD, Weinstein AS, Weissman BN, Young DY. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum. 1985;28:16–24.
   PubMed Web of Science ®Google Scholar
• Ishizuka N, Ishizuka Y, Yoda E, Hashimoto H, Nagai R, YamakadoM. Association between white blood cell count and carotid arterio-sclerosis in Japanese smokers. Atherosclerosis. 2004;175:95–100.
   PubMed Web of Science ®Google Scholar
• Tokyo Health Service Association. Available at: http://www. yobouigaku-tokyo.or.jp (in Japanese).
   Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.
   Google Scholar
• Kubota A, Hasegawa K, Suguro T, Koshihara Y. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. J Rheumatol. 2004;31:426–35.
   PubMed Web of Science ®Google Scholar
• Dhore CR, Cleutjens JPM, Lutgens E, Cleutjens KBJM, Geusens PPM, Kitslaar PJEHM, Tordoir JHM, Spronk HMH, Vermeer S, Daemen MJAP. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998–2003.
   PubMed Web of Science ®Google Scholar
• Ovchinnikova 0, Gylfe A, Bailey L, Nordstrom S, Waldenstrom A, Hansson GK, Nordstrom P. Osteoprotegerin promoted fibrous cap formation in atherosclerotic lesions of apoE-deficient mice. Arterioscler Thromb Vasc Biol. 2009;29:1478–80.
   PubMed Web of Science ®Google Scholar
• Omland T, Ueland T, Jonsson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, et al. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syn-dromes. J Am Coll Cardiol. 2008;51:627–33.
   PubMed Web of Science ®Google Scholar
• Asanuma Y, Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007;195:e135–41.
   Google Scholar
• Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coro-nary artery disease events: a meta-analysis. Atherosclerosis. 2012;220:128–33.
   Google Scholar
• Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rine& I. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum. 2011;63:1211–20.
   Google Scholar
• Syversen SW, Goll GL, van der Heijde D, Landewe R, Gaarder PI, Odegäre S, haavardsholm EA, Kvien TK. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radio-graphic progression. J Rheumatol. 2009;36: 266–72.
   Google Scholar